QFW
GILD icon

QTR Family Wealth’s Gilead Sciences GILD Stock Holding History

QTR Family Wealth’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$310K Hold
2,207
– – 0.13% 188
2025
Q4 		$325K Buy
2,207
+155
+8% +$18.8K 0.14% 167
2025
Q3 		$228K Buy
2,052
+3
+0.1% +$341 0.11% 219
2025
Q2 		$227K Buy
2,049
+104
+5% +$11.1K 0.14% 156
2025
Q1 		$218K Buy
+1,945
New +$201K 0.16% 147

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

QTR Family Wealth's GILD Position: Q1 2026 in Review

QTR Family Wealth held its Gilead Sciences (GILD) position steady in Q1 2026 at 2,207 shares worth $310K. The position accounts for 0.13% of the portfolio, ranked #188.

QTR Family Wealth first reported a position in GILD in Q1 2025 and has held it in 5 quarters since. The position peaked at $325K in Q4 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • QTR Family Wealth held 2,207 shares of Gilead Sciences worth $310K as of Q1 2026.
  • QTR Family Wealth left its Gilead Sciences share count unchanged in Q1 2026.
  • Gilead Sciences made up 0.13% of QTR Family Wealth's portfolio in Q1 2026, its #188 holding.
  • QTR Family Wealth first reported a position in Gilead Sciences in Q1 2025 and has held it in 5 quarters since.
  • QTR Family Wealth's Gilead Sciences position peaked at $325K in Q4 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on QTR Family Wealth's 13F filing for Q1 2026, filed 16 Apr 2026.